Munafa Stock Market Course + Intraday & FNO calls 
Tandem Diabetes (TNDM) Technical (Analysis) Reports Tandem Diabetes ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Tandem Diabetes (TNDM)
Technical Analysis Report for USA stock TNDM Tandem Diabetes. Dated: 02 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Medical Dental Instruments in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock TNDM Tandem Diabetes then click here. or read Experts views on Tandem Diabetes or Forecast & share price targets of Tandem Diabetes
Tandem Diabetes Opened at 16.66 and Closed at: 16.50, which is 0% of previous session's close. It moved within a range of 16.27 and 17.35
The session was a Bearish session with an average volume of 2194600, which is -9.46% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 15.85 and resistance for tomorrow is 16.93
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 16.06, 15.63 resistance for tomorrow's hourly charts is 17.14, 17.79
10 Day SMA for Tandem Diabetes (TNDM) is 16.47 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Tandem Diabetes (TNDM) is 17.19 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Tandem Diabetes (TNDM) is 19.52 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 17.79 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Tandem Diabetes is 19.37 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Tandem Diabetes is at 17.19 and 200 DMA is at 19.37, while 50 DMA and 100 DMA are at 19.52 and 17.79 respectively
Tandem Diabetes (TNDM) moving average of 20 SMA is at 17.19 and 20 EMA is at 17.36
| Date | Closing Price | 20 SMA | 20 EMA |
| 02 Fri Oct | 16.50 | 17.19 | 17.36 |
| 01 Thu Oct | 16.50 | 17.39 | 17.45 |
| 30 Wed Sep | 16.31 | 17.59 | 17.55 |
| 29 Tue Sep | 16.57 | 17.84 | 17.68 |
| 28 Mon Sep | 16.42 | 18.11 | 17.8 |
| 25 Fri Sep | 15.72 | 18.36 | 17.95 |
Tandem Diabetes (TNDM) moving average of 50 SMA is at 19.52 and 50 EMA is at 18.33
| Date | Closing Price | 50 SMA | 50 EMA |
| 02 Fri Oct | 16.50 | 19.52 | 18.33 |
| 01 Thu Oct | 16.50 | 19.54 | 18.4 |
| 30 Wed Sep | 16.31 | 19.54 | 18.48 |
| 29 Tue Sep | 16.57 | 19.56 | 18.57 |
| 28 Mon Sep | 16.42 | 19.58 | 18.65 |
| 25 Fri Sep | 15.72 | 19.61 | 18.74 |
Tandem Diabetes (TNDM) moving average of 100 SMA is at 17.79 and 100 EMA is at 18.5
| Date | Closing Price | 100 SMA | 100 EMA |
| 02 Fri Oct | 16.50 | 17.79 | 18.5 |
| 01 Thu Oct | 16.50 | 17.77 | 18.54 |
| 30 Wed Sep | 16.31 | 17.75 | 18.58 |
| 29 Tue Sep | 16.57 | 17.74 | 18.63 |
| 28 Mon Sep | 16.42 | 17.76 | 18.67 |
| 25 Fri Sep | 15.72 | 17.78 | 18.72 |
Tandem Diabetes (TNDM) moving average of 200 SMA is at 19.37 and 200 EMA is at 18.59
| Date | Closing Price | 200 SMA | 200 EMA |
| 02 Fri Oct | 16.50 | 19.37 | 18.59 |
| 01 Thu Oct | 16.50 | 19.4 | 18.61 |
| 30 Wed Sep | 16.31 | 19.43 | 18.63 |
| 29 Tue Sep | 16.57 | 19.46 | 18.65 |
| 28 Mon Sep | 16.42 | 19.48 | 18.67 |
| 25 Fri Sep | 15.72 | 19.5 | 18.69 |
Repligen Corporation has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Repligen Corporation, about 25.5% more returns!
Phio Pharmaceuticals has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 8.76% more returns!
Pro Dex has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Pro Dex, about 4.37% more returns!
Outlook Therapeutics has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Outlook Therapeutics, about 5.15% more returns!
Tandem Diabetes has performed better than Ocular Therapeutix in short term. Holding Tandem Diabetes could be a better choice for now!
Tandem Diabetes has performed better than Meiragtx Holdings in short term. Holding Tandem Diabetes could be a better choice for now!
Medpace Holdings has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Medpace Holdings, about 18.47% more returns!
Tandem Diabetes has performed better than Inovio Pharmaceuticals in short term. Holding Tandem Diabetes could be a better choice for now!
Eyegate Pharmaceuticals has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 13.86% more returns!
Cytosorbents Corporation has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Cytosorbents Corporation, about 1042.09% more returns!
Tandem Diabetes has performed better than Autolus Therapeutics in short term. Holding Tandem Diabetes could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 15.54% more returns!
Ascendis Pharma has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Ascendis Pharma, about 1.31% more returns!
Addus Homecare has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Addus Homecare, about 10.78% more returns!
Tenet Healthcare has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Tenet Healthcare, about 14.66% more returns!
Resmed Inc has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Resmed Inc, about 12.95% more returns!
Tandem Diabetes has performed better than Concord Medical in short term. Holding Tandem Diabetes could be a better choice for now!
Brookdale Senior has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Brookdale Senior, about 9.36% more returns!
Becton Dickinson has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Becton Dickinson, about 12.79% more returns!
Tandem Diabetes Technical analysis of indicators
Price action analysis of Tandem Diabetes (TNDM) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Tandem Diabetes stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Tandem Diabetes in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Tandem Diabetes Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Tandem Diabetes in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Tandem Diabetes is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 16.44 and Tandem Diabetes TNDM stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Tandem Diabetes TNDM stock. Volume based technical analysis of Tandem Diabetes TNDM stock is negative.
Tandem Diabetes Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock TNDM Tandem Diabetes These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And TNDM Experts View which covers a lot of information including buying and selling signals
TNDM future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Tandem Diabetes or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Tandem Diabetes (TNDM) Technical (Analysis) Reports Tandem Diabetes ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
